vs

Side-by-side financial comparison of ARTS WAY MANUFACTURING CO INC (ARTW) and Spectral AI, Inc. (MDAI). Click either name above to swap in a different company.

ARTS WAY MANUFACTURING CO INC is the larger business by last-quarter revenue ($5.1M vs $4.1M, roughly 1.2× Spectral AI, Inc.). Spectral AI, Inc. runs the higher net margin — 25.7% vs -12.7%, a 38.5% gap on every dollar of revenue. On growth, ARTS WAY MANUFACTURING CO INC posted the faster year-over-year revenue change (-17.9% vs -46.3%). Over the past eight quarters, ARTS WAY MANUFACTURING CO INC's revenue compounded faster (-5.9% CAGR vs -19.6%).

Art's Way Manufacturing is an American producer of agricultural machinery, modular buildings and cutting tools under the brand names Art's Way, Art's Way Scientific and American Carbide Tool. The firm previously manufactured OEM feed blowers sold by Case New Holland.

Spectral AI, Inc. is a medical technology firm specializing in AI-powered diagnostic imaging solutions primarily for burn and wound care. It develops non-invasive imaging tools that enable healthcare providers to deliver faster, more accurate treatment assessments, serving clinical and healthcare partner networks across North America and European markets.

ARTW vs MDAI — Head-to-Head

Bigger by revenue
ARTW
ARTW
1.2× larger
ARTW
$5.1M
$4.1M
MDAI
Growing faster (revenue YoY)
ARTW
ARTW
+28.4% gap
ARTW
-17.9%
-46.3%
MDAI
Higher net margin
MDAI
MDAI
38.5% more per $
MDAI
25.7%
-12.7%
ARTW
Faster 2-yr revenue CAGR
ARTW
ARTW
Annualised
ARTW
-5.9%
-19.6%
MDAI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARTW
ARTW
MDAI
MDAI
Revenue
$5.1M
$4.1M
Net Profit
$-645.5K
$1.1M
Gross Margin
18.6%
45.2%
Operating Margin
-11.2%
-54.9%
Net Margin
-12.7%
25.7%
Revenue YoY
-17.9%
-46.3%
Net Profit YoY
-177.6%
113.9%
EPS (diluted)
$-0.13
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARTW
ARTW
MDAI
MDAI
Q4 25
$5.1M
$4.1M
Q3 25
$6.4M
$3.8M
Q2 25
$6.3M
$5.1M
Q1 25
$5.1M
$6.7M
Q4 24
$6.2M
$7.6M
Q3 24
$5.9M
$8.2M
Q2 24
$6.7M
$7.5M
Q1 24
$5.7M
$6.3M
Net Profit
ARTW
ARTW
MDAI
MDAI
Q4 25
$-645.5K
$1.1M
Q3 25
$254.1K
$-3.6M
Q2 25
$1.5M
$-8.0M
Q1 25
$-55.8K
$2.9M
Q4 24
$832.0K
$-7.6M
Q3 24
$-26.2K
$-1.5M
Q2 24
$-33.3K
$-2.9M
Q1 24
$-465.0K
$-3.2M
Gross Margin
ARTW
ARTW
MDAI
MDAI
Q4 25
18.6%
45.2%
Q3 25
27.5%
42.7%
Q2 25
32.5%
45.2%
Q1 25
29.1%
47.2%
Q4 24
36.1%
44.0%
Q3 24
28.9%
44.9%
Q2 24
28.3%
44.3%
Q1 24
25.7%
46.6%
Operating Margin
ARTW
ARTW
MDAI
MDAI
Q4 25
-11.2%
-54.9%
Q3 25
5.4%
-88.1%
Q2 25
8.1%
-41.9%
Q1 25
0.0%
-13.4%
Q4 24
8.4%
-14.6%
Q3 24
2.6%
-10.8%
Q2 24
2.5%
-32.7%
Q1 24
-6.6%
-33.9%
Net Margin
ARTW
ARTW
MDAI
MDAI
Q4 25
-12.7%
25.7%
Q3 25
4.0%
-93.7%
Q2 25
23.4%
-157.3%
Q1 25
-1.1%
43.2%
Q4 24
13.5%
-99.8%
Q3 24
-0.4%
-18.4%
Q2 24
-0.5%
-38.3%
Q1 24
-8.1%
-50.7%
EPS (diluted)
ARTW
ARTW
MDAI
MDAI
Q4 25
$-0.13
$0.04
Q3 25
$0.05
$-0.13
Q2 25
$0.29
$-0.31
Q1 25
$-0.01
$0.11
Q4 24
$0.17
$-0.42
Q3 24
$-0.01
$-0.08
Q2 24
$-0.01
$-0.16
Q1 24
$-0.09
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARTW
ARTW
MDAI
MDAI
Cash + ST InvestmentsLiquidity on hand
$4.8K
$15.4M
Total DebtLower is stronger
$2.5M
$9.3M
Stockholders' EquityBook value
$13.3M
$-5.7M
Total Assets
$22.5M
$21.4M
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARTW
ARTW
MDAI
MDAI
Q4 25
$4.8K
$15.4M
Q3 25
$6.0K
$10.5M
Q2 25
$4.5K
$10.5M
Q1 25
$4.1K
$14.1M
Q4 24
$1.9K
$5.2M
Q3 24
$5.1K
$3.7M
Q2 24
$4.5K
$6.9M
Q1 24
$2.5K
$10.2M
Total Debt
ARTW
ARTW
MDAI
MDAI
Q4 25
$2.5M
$9.3M
Q3 25
Q2 25
Q1 25
$7.8M
Q4 24
$2.1M
$2.8M
Q3 24
$2.7M
$1.0M
Q2 24
$2.7M
Q1 24
$2.7M
Stockholders' Equity
ARTW
ARTW
MDAI
MDAI
Q4 25
$13.3M
$-5.7M
Q3 25
$13.9M
$-8.2M
Q2 25
$13.6M
$-9.2M
Q1 25
$12.1M
$-1.6M
Q4 24
$12.1M
$-7.3M
Q3 24
$11.3M
$-4.8M
Q2 24
$11.2M
$-4.7M
Q1 24
$11.2M
$-2.5M
Total Assets
ARTW
ARTW
MDAI
MDAI
Q4 25
$22.5M
$21.4M
Q3 25
$21.8M
$15.3M
Q2 25
$20.9M
$16.0M
Q1 25
$21.0M
$20.7M
Q4 24
$21.2M
$12.1M
Q3 24
$23.5M
$11.6M
Q2 24
$23.2M
$13.9M
Q1 24
$24.3M
$15.5M
Debt / Equity
ARTW
ARTW
MDAI
MDAI
Q4 25
0.19×
Q3 25
Q2 25
Q1 25
Q4 24
0.17×
Q3 24
0.24×
Q2 24
0.24×
Q1 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARTW
ARTW
MDAI
MDAI
Operating Cash FlowLast quarter
$-889.2K
$-2.6M
Free Cash FlowOCF − Capex
$-1.0M
FCF MarginFCF / Revenue
-20.6%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
-2.43×
TTM Free Cash FlowTrailing 4 quarters
$-1.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARTW
ARTW
MDAI
MDAI
Q4 25
$-889.2K
$-2.6M
Q3 25
$-1.3M
$-2.5M
Q2 25
$1.4M
$-3.4M
Q1 25
$-101.8K
$-1.5M
Q4 24
$1.2M
$469.0K
Q3 24
$282.4K
$-1.6M
Q2 24
$1.2M
$-5.4M
Q1 24
$-99.3K
$-2.7M
Free Cash Flow
ARTW
ARTW
MDAI
MDAI
Q4 25
$-1.0M
Q3 25
$-1.5M
Q2 25
$1.2M
Q1 25
$-184.5K
Q4 24
$1.1M
Q3 24
$180.5K
Q2 24
$1.0M
Q1 24
$-380.4K
FCF Margin
ARTW
ARTW
MDAI
MDAI
Q4 25
-20.6%
Q3 25
-23.8%
Q2 25
19.3%
Q1 25
-3.6%
Q4 24
17.6%
Q3 24
3.1%
Q2 24
15.1%
Q1 24
-6.6%
Capex Intensity
ARTW
ARTW
MDAI
MDAI
Q4 25
3.0%
Q3 25
4.1%
Q2 25
2.1%
Q1 25
1.6%
Q4 24
1.8%
Q3 24
1.7%
Q2 24
3.4%
Q1 24
4.9%
Cash Conversion
ARTW
ARTW
MDAI
MDAI
Q4 25
-2.43×
Q3 25
-4.99×
Q2 25
0.91×
Q1 25
-0.52×
Q4 24
1.44×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARTW
ARTW

Agricultural Products$2.8M55%
Modular Buildings$2.2M44%

MDAI
MDAI

Segment breakdown not available.

Related Comparisons